Emodin suppresses lipopolysaccharide-induced pro-inflammatory responses and NF-κB activation by disrupting lipid rafts in CD14-negative endothelial cells
about
MYADM controls endothelial barrier function through ERM-dependent regulation of ICAM-1 expressionSan-Huang-Xie-Xin-Tang Constituents Exert Drug-Drug Interaction of Mutual Reinforcement at Both Pharmacodynamics and Pharmacokinetic Level: A ReviewMechanosensitive caveolin-1 activation-induced PI3K/Akt/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis in vivoReview of clinical studies of Polygonum multiflorum Thunb. and its isolated bioactive compoundsCyanidin-3-O-β-glucoside inhibits lipopolysaccharide-induced inflammatory response in mouse mastitis model.Multifunctional core/shell nanoparticles cross-linked polyetherimide-folic acid as efficient Notch-1 siRNA carrier for targeted killing of breast cancerEmodin inhibits tonic tension through suppressing PKCδ-mediated inhibition of myosin phosphatase in rat isolated thoracic aortaAdhesion of bio-functionalized ultrasound microbubbles to endothelial cells by targeting to vascular cell adhesion molecule-1 under shear flow.Emodin ameliorates lipopolysaccharides-induced corneal inflammation in rats.Anti-inflammatory effect of emodin on lipopolysaccharide-induced keratitis in Wistar rats.Novel Anthra[1,2-c][1,2,5]Thiadiazole-6,11-Diones as Promising Anticancer Lead Compounds: Biological Evaluation, Characterization & Molecular Targets DeterminationEmodin regulating excision repair cross-complementation group 1 through fibroblast growth factor receptor 2 signaling.VCAM-1-targeted core/shell nanoparticles for selective adhesion and delivery to endothelial cells with lipopolysaccharide-induced inflammation under shear flow and cellular magnetic resonance imaging in vitroEmodin attenuates systemic and liver inflammation in hyperlipidemic mice administrated with lipopolysaccharides.Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3Emodin Isolated from Polygoni cuspidati Radix Inhibits TNF-α and IL-6 Release by Blockading NF-κB and MAP Kinase Pathways in Mast Cells Stimulated with PMA Plus A23187.Phospholipase D from Loxosceles laeta Spider Venom Induces IL-6, IL-8, CXCL1/GRO-α, and CCL2/MCP-1 Production in Human Skin Fibroblasts and Stimulates Monocytes Migration.Synergistic effects of curcumin with emodin against the proliferation and invasion of breast cancer cells through upregulation of miR-34a.Downregulation of phosphatase of regenerating liver-3 is involved in the inhibition of proliferation and apoptosis induced by emodin in the SGC-7901 human gastric carcinoma cell line.Anti-inflammatory activities of Reynoutria elliptica through suppression of mitogen-activated protein kinases and nuclear factor-κB activation pathways.Emodin inhibits HMGB1-induced tumor angiogenesis in human osteosarcoma by regulating SIRT1.Emodin improves lipopolysaccharide-induced microcirculatory disturbance in rat mesentery.Sodium tanshinone IIA sulfonate prevents lipopolysaccharide-induced inflammation via suppressing nuclear factor-κB signaling pathway in human umbilical vein endothelial cells.Therapeutic effect of emodin on collagen-induced arthritis in mice.The study on the material basis and the mechanism for anti-renal interstitial fibrosis efficacy of rhubarb through integration of metabonomics and network pharmacology.AIBP augments cholesterol efflux from alveolar macrophages to surfactant and reduces acute lung inflammationEmodin Attenuates Lipopolysaccharide-Induced Acute Liver Injury via Inhibiting the TLR4 Signaling Pathway and
P2860
Q24306882-3509D047-BCB4-4FD1-BD87-697CE9CE91F0Q28075782-605E353B-7535-42DF-804C-483E8A3FF4A5Q28383915-AF4D3A8B-485F-4CE7-9120-CB38CA3D0B59Q30408018-E83E70DD-2494-4F21-8B9E-C6BF84678BE0Q33653629-769D702C-9D10-4D37-8528-7BEDA61A242DQ34519604-65D3437D-83C0-4B89-B197-06F339AE7792Q34559604-13E06312-058E-45B3-9A65-AC4D258501DBQ35234733-02DAC8E0-7B6A-45EC-BC3B-1A4D4B5D36C5Q35755680-1785C82A-53EF-41F9-AEC6-EBEF7F2B4482Q35835761-2D1C24BA-7B52-4994-A080-32513C1A57A4Q35996034-3A5B238D-1EC8-438C-8D6F-979479C6CC35Q36821624-030D55EE-C15C-49F1-B630-887F146B23BCQ36857241-25E26C76-20B3-42EE-9A0D-DF72BFAE8BD2Q37184304-EFCDB2A2-6857-477D-A703-9A8966B8792DQ37237164-C17E1021-1148-4E9D-BFBC-1CDB59C0F93DQ37429748-6B6A456F-602B-45D7-AF82-8C5DFE372822Q38853426-C5774414-E3FE-44D0-A1B4-356BB6C8123AQ39138948-F609146D-1206-42A4-BA4D-796A54A64401Q39280610-2CC910A5-E218-4D05-9179-1ECA5FF59F83Q39465293-A58ADA62-BA30-4ACC-AB69-A1F88B9CAF72Q41995659-0CD04922-4931-4AC1-8C30-0AD1537125A0Q44512582-B130145A-4C31-4219-9794-733F6F62227AQ47990226-08B01429-DFAA-4DBB-B8CF-22828B6AA3EFQ50943499-2537637C-D6F6-408A-9362-A576C7C87E22Q51013862-27E27BC7-D943-4D9C-816D-0773A336673EQ58710934-47F5396C-4DDC-4EC0-AAC3-789B22F7730EQ58719532-980F6319-43E1-432B-91E7-08F0EB44DD4E
P2860
Emodin suppresses lipopolysaccharide-induced pro-inflammatory responses and NF-κB activation by disrupting lipid rafts in CD14-negative endothelial cells
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Emodin suppresses lipopolysacc ...... D14-negative endothelial cells
@ast
Emodin suppresses lipopolysacc ...... D14-negative endothelial cells
@en
Emodin suppresses lipopolysacc ...... D14-negative endothelial cells
@nl
type
label
Emodin suppresses lipopolysacc ...... D14-negative endothelial cells
@ast
Emodin suppresses lipopolysacc ...... D14-negative endothelial cells
@en
Emodin suppresses lipopolysacc ...... D14-negative endothelial cells
@nl
prefLabel
Emodin suppresses lipopolysacc ...... D14-negative endothelial cells
@ast
Emodin suppresses lipopolysacc ...... D14-negative endothelial cells
@en
Emodin suppresses lipopolysacc ...... D14-negative endothelial cells
@nl
P2093
P2860
P921
P1476
Emodin suppresses lipopolysacc ...... D14-negative endothelial cells
@en
P2093
Changchun Lou
Guoquan Meng
P2860
P304
P356
10.1111/J.1476-5381.2010.00993.X
P407
P577
2010-12-01T00:00:00Z